Please login to the form below

sexual dysfunction

This page shows the latest sexual dysfunction news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Sprout Pharma's 'female Viagra'

The panel voted by 18 to 6 that the drug - called flibanserin - should be approved to treat hypoactive sexual desire disorder (HSDD) in pre-menopausal women, opening the door for a ... However, the committee said that given the intended use of the drug

Latest news

Lundbeck launches Brintellix in first EU market

Clinical trial results suggest Brintellix is at least as effective as Lexapro in adult patients with major depressive disorders and is significantly less likely to cause sexual dysfunction, a common problem
Menarini to raise awareness of sexual dysfunction

The rugby player ambassadors of Menarini's sexual dysfunction campaign. Italian pharma company A. ... Menarini Farmaceutica Internazionale has launched a campaign to address poor awareness of sexual dysfunction in the UK.
Making a big splash

Whether you are treating heart disease or sexual dysfunction, the biggest competitor we face is often doing nothing.
It's all in the detail

Defined by specific diseases, eg, psoriasis, rheumatoid arthritis, erectile dysfunction, etc, these groups will often discuss the topic in an oblique way. ... For example, erectile dysfunction conversations are often around sexual self-confidence, which
Endo testosterone gel approved

Hypogonadism, or low testosterone, can lead to erectile dysfunction, fatigue, regression of secondary sexual characteristics and osteoporosis.

More from news
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest Intelligence

Deal Watch February 2017

Acquisition - business unit. 1, 045. EndoCeutics/ AMAG Pharmaceuticals. Intraros (prasterone), non-oestrogen product for postmenopausal atrophic vaginitis (FDA approved), female sexual dysfunction (phase III).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Engagement Specialist, Healthcare Brand Communications, London, ...: circa £50K

Medical Writer: Salary TBC

Account Director – Healthcare Marketing – Berks: Salary TBC

Digital Communications Lead, Healthcare Brand and Medical Commun...: up to £50K

Senior Account Manager: Competitive Salary Offered

Senior Account Executive with progression to Account Manager, Me...: Excellent package

Associate Director: £75, 000-90, 000

Account Manager: Negotiable

Associate Medical Director: Excellent PTO, bonus and 401k package

Account Manager / Senior Account Manager: 35, 000-40, 000

Medical Writer: Bonus Scheme, PTO &Private Healthcare

SAE – Healthcare PR – Award-Winning Consultancy: Salary TBC

Account Executive/ Senior Account Executive: competitive Salary Offfered

Account Manager- Healthcare Advertising: Negotiable

Manager - Immunology, Therapeutic Area Communications & Publ...: Competitive Salary Offered

Account Director: Competitive Salary Offered

Senior Editorial Assistant – Greater Manchester: DOE

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Developer with management potential, Healthcare Brand Com...: circa £50K

Systematic Reviewer - Oxford: Negotiable

Medical (Scientific) Director: £120, 000 benefits

CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...: EXCELLENT DAY RATES AVAILABLE

Editorial Manager - MedComms: DOE

Account Manager / Account Director: Competative

Healthcare Communications Account Directors x 2: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

AstraZeneca’s oncology renaissance: Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis: Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls: ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...